Determinants of histamine recognition: Implications for the design of antihistamines

Biochemical and Biophysical Research Communications

Volumn 309, Issue 2, 2003, Pages 425-431

  Konkimalla, V Badireenath ^a,b   Chandra, Nagasuma ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Binding modes; Histamine; Side effects; Specific design; Structural comparison; Structural determinants

Indexed keywords

ANTIHISTAMINIC AGENT; BINDING PROTEIN; HISTAMINE; HISTAMINE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

EID: 0041923826     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.023     Document Type: Article

References (28)

1. Green J.P., Johnson C.L., Weinstein H. Histamine as a neurotransmitter. Lipton M.A., Di Mascio A., Killman K.F. Psychopharmacology: A Generation of Progress. 1978;319-332 Raven press, New York.
2. Lorenz W., Thon K., Barth H., Neugebauer E., Reimann H.J., Kusche J. Metabolism and function of gastric histamine in health and disease. J. Clin. Gastroenterol. 5(Suppl. 1):1983;37-56.
3. Pearlman D.S. Antihistamines: pharmacology and clinical use. Drugs. 12:1976;258-273.
4. Oppenheimer J.J., Casale T.B. Next generation antihistamines: therapeutic rationale, accomplishments and advances. Expert Opin. Investig. Drugs. 11:2002;807-817.
5. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 287:2002;337-344.
6. Yap Y.G., Camm A.J. The current cardiac safety situation with antihistamines. Clin. Exp. Allergy. 29(Suppl. 1):1999;15-24.
7. Philpot E.E. Safety of second generation antihistamines. Allergy Asthma Proc. 21:2000;15-20.
8. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., Bourne P.E. The protein data bank. Nucleic Acids Res. 28:2000;235-242.
9. Goto S., Okuno Y., Hattori M., Nishioka T., Kanehisa M. LIGAND: database of chemical compounds and reactions in biological pathways. Nucleic Acids Res. 30:2002;402-404.
10. Worley S., Schelp E., Monzingo A.F., Ernst S., Robertus J.D. Structure and cooperativity of a T-state mutant of histidine decarboxylase from Lactobacillus 30a. Proteins. 46:2002;321-329.
11. Gallagher T., Rozwarski D.A., Ernst S.R., Hackert M.L. Refined structure of the pyruvoyl-dependent histidine decarboxylase from Lactobacillus 30a. J. Mol. Biol. 230:1993;516-528.
12. Horton J.R., Sawada K., Nishibori M., Zhang X., Cheng X. Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons. Structure. 9:2001;837-849.
13. Wilmot C.M., Murray J.M., Alton G., Parsons M.R., Convery M.A., Blakeley V., Corner A.S., Palcic M.M., Knowles P.F., McPherson M.J., Phillips S.E. Catalytic mechanism of the quinoenzyme amine oxidase from Escherichia coli: exploring the reductive half-reaction. Biochemistry. 36:1997;1608-1620.
14. Weinshilboum R.M., Otterness D.M., Szumlanski C.L. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39:1999;19-52.
15. Stein C., Weinreich D.J. An in vitro characterization of gamma-glutamylhistamine synthetase: a novel enzyme catalyzing histamine metabolism in the central nervous system of the marine mollusk, Aplysia californica. J. Neurochem. 38:1982;204-214.
16. Aisien S.O., Walter R.D. Biogenic-amine acetylation: an additional function of the N-acetyltransferase from Fasciola hepatica. Biochem. J. 291:1993;733-737.
17. Barbosa J.R.R.G., Sivaraman J., Li Y., Larocque R., Matte A., Schrag J.D., Cygler M. Mechanism of action and Nad+-Binding mode revealed by the crystal structure of L-histidinol dehydrogenase. Proc. Natl. Acad. Sci. USA. 99:2002;1859-1864.
18. Briganti F., Mangani S., Orioli P., Scozzafava A., Vernaglione G., Supuran C.T. Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. Biochemistry. 36:1997;10384-10392.
19. Stark H., Sippl W., Ligneau X., Arrang J.M., Ganellin C.G., Schwartz J.C., Schunack W. Different antagonist binding properties of human and rat histamine H3 receptors. Bioorg. Med. Chem. Lett. 11:2001;51-954.
20. Sippl W., Stark H., Holtje H.D. Development of a binding site model for histamine H3-receptor agonists. Pharmazie. 53:1998;433-437.
21. Shin N., Coates E., Murgolo N.J., Morse K.L., Bayne M., Strader C.D., Monsma F.J. Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. Mol. Pharmacol. 62:2002;38-47.
22. Montfort W.R., Weichsel A., Andersen J.F. Nitrophorins and related antihemostatic lipocalins from Rhodnius prolixus and other blood-sucking arthropods. Biochim. Biophys. Acta. 1482:2000;110-118.
23. Andersen J.F., Weichsel A., Balfour C.A., Champagne D.E., Montfort W.R. The crystal structure of nitrophorin 4 at 1.5 Å resolution: transport of nitric oxide by a lipocalin-based heme protein. Structure. 6:1998;1315-1327.
24. Paesen G.C., Adams P.L., Harlos K., Nuttal P.A., Stuart D.I. Tick histamine-binding proteins: isolation, cloning and three-dimensional structure. Mol. Cell. 3:1999;661-671.
25. Kremer J.M., Wilting J., Janssen L.H. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol. Rev. 40:1988;1-47.
26. Brunner F., Muller W.E. The stereoselectivity of the 'single drug binding site' of human alpha 1-acid glycoprotein (orosomucoid). J. Pharm. Pharmacol. 39:1987;986-990.
27. Richards W.G., Aschman D.G., Hammond J. Conformational flexibility in physiologically active amines. J. Theor. Biol. 2:1975;223-230.
28. Sobolev V., Sorokine A., Prilusky J., Abola E.E., Edelman M. Automated analysis of interatomic contacts in proteins (LPC). Bioinformatics. 15:1999;327-332.